Post

Clinical trials are the initial spark that drives the engine of pharmaceutical products; they are critical for demonstrating product success. But we have observed that in rare diseases (like many oncology indications), there is a gap between patient perception of clinical trials and the expectations from trial executors and sponsoring companies. Ma...